Your session is about to expire
← Back to Search
N-TORM Emergency Preparedness for Vulnerable Populations
N/A
Waitlist Available
Led By Tara Heagele, PhD, RN
Research Sponsored by Hunter College of City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
Study Summary
This trial is testing a Korean translation of a household emergency preparedness instrument, and will also be testing the effectiveness of an emergency preparedness intervention provided by nurses.
Who is the study for?
This trial is for adults over 18 who live independently in the New York metropolitan area, can consent to participate, and are able to understand and read Korean. It's not open to those under 18, with cognitive impairments, or who cannot speak or read Korean.Check my eligibility
What is being tested?
The study tests a nurse-led emergency preparedness program (N-TORM) alongside the Korean translation of an emergency readiness tool (K-HEPI). The goal is to see if N-TORM improves knowledge and actions related to preparing for emergencies among vulnerable populations.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. Participants may experience stress or anxiety when discussing emergency scenarios.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Korean Household Emergency Preparedness Instrument (K-HEPI) Score
Secondary outcome measures
Potassium
Participant experience with the N-TORM Intervention
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
This is a phase 1 feasibility study via a cluster randomized controlled trial.
Group II: Control GroupActive Control1 Intervention
The control group will receive the Korean version of the 2-page Prepared New York: Disaster and Emergency Preparation pocket guide (NYC Emergency Management, n.d.) after data collection has been completed.
Find a Location
Who is running the clinical trial?
Hunter College of City University of New YorkLead Sponsor
38 Previous Clinical Trials
8,635 Total Patients Enrolled
1 Trials studying Vulnerable Populations
31 Patients Enrolled for Vulnerable Populations
Tara Heagele, PhD, RNPrincipal InvestigatorCity University of New York, School of Public Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are unable to read and understand the Korean language.You have difficulty thinking, learning, or remembering things.You are able to read and understand Korean.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Group
- Group 2: Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there availability for enrolment in this research project?
"According to clinicaltrials.gov, this medical research experiment is no longer recruiting patients; the first posting date was November 1st 2022 and it was modified on September 14th 2022. However, 191 other trials are presently engaging participants in their studies."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger